-/-Fmod -/-mice. The up-regulation of both catabolic and anabolic agents did not appear to positively affect the overall growth of Bgn -/-Fmod -/-condyles compared to WT controls. In summary, the up-regulation of both anabolic and catabolic genes in the WT and Bgn -/-Fmod -/-TMJs treated with BMP-2 suggests that BMP increases matrix turnover in the condyle, and, further, that Bgn and Fmod could have protective roles in regulating this process.
BMP-2, and this up-regulation was significantly enhanced in the Bgn -/-Fmod -/-mice. The up-regulation of both catabolic and anabolic agents did not appear to positively affect the overall growth of Bgn -/-Fmod -/-condyles compared to WT controls. In summary, the up-regulation of both anabolic and catabolic genes in the WT and Bgn -/-Fmod -/-TMJs treated with BMP-2 suggests that BMP increases matrix turnover in the condyle, and, further, that Bgn and Fmod could have protective roles in regulating this process. 
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Introduction
Temporomandibular joint (TMJ) disorders afflict approximately 5-10% of the US population [Liu and Steinkeler, 2013] . These disorders encompass a collection of at least 12 clinical phenotypes, one of which is degenerative TMJ disease [Schiffman et al., 2014] . Individuals with this degenerative joint disease experience irreversible damage to the joint complex, including degradation and loss of extracellular matrix (ECM) proteins necessary for joint function. Unfortunately, in most cases, this irreversible damage occurs before symptoms present and the disease is diagnosed [Wang et al., 2015] . Therefore, efforts to identify markers and molecular mechanisms characteristic of degenerative TMJ disease in the early phases are needed to detect and develop treatments that can prevent the irreversible process of the disease.
The TMJ is a unique articulating joint comprised of the mandibular condyle which fits into the mandibular fossa of the temporal bone. The articular disk and the articular cartilage of the condyle are both fibrocartilaginous tissues that cover these two bones and promote articulation. The fibrocartilage of the mandibular condyle is comprised of ECM proteins and proteoglycans that provide the necessary properties to support the loads on the condyle during mastication and verbal communication. Within this ECM, there exists small leucine-rich proteoglycans (SLRPs) including biglycan (Bgn) and fibromodulin (Fmod), which play a role in sequestration of important signaling molecules and regulating collagen fibrillogenesis [Ameye and Young, 2002] . Specifically, Bgn and Fmod modulate TGF super family signaling activity, including bone morphogenetic protein (BMP) signaling [Wadhwa et al., 2004; Young et al., 2006] . BMP signaling has well-established roles in chondrogenesis and endochondral bone formation [Long and Ornitz, 2013] . Abnormal activation of this signaling causes heterotopic cartilage and bone formation [Billings et al., 2008; Huegel et al., 2015] . Specifically, excessive BMP-2 signaling has recently been shown to be involved in heterotopic cartilage formation and the pathogenesis of TMJ osteoarthritis (OA) [Albilia et al., 2013; Bechtold et al., 2016] . However, the mechanism of excessive BMP-2 signaling on the mandibular condylar cartilage and its implications in TMJ-OA are unknown.
We have previously developed a murine model with accelerated TMJ-OA in mice double-deficient in Bgn and Fmod ( Bgn
). Using this model, we determined that Bgn -/-Fmod -/-mice develop TMJ-OA at 6-9 months of age whereas WT mice develop TMJ-OA at 12-18 months of age [Wadhwa et al., 2005a [Wadhwa et al., , 2005b Chen et al., 2009] . Consequently, the goal of this study was to examine BMP-2 signaling in Bgn
Fmod
-/-mice. We hypothesized that BMP-2 treatment would promote overactivation of chondrogenic markers in the absence of Bgn and Fmod compared to WT mice due to dysregulation of the signaling pathway. Greater understanding of the early signaling events that mediate TMJ-OA is critical in the development of diagnostic tools and interventional therapeutics. 
Materials and Methods
Animals
Fmod
-/-have been reported previously [Wadhwa et al., 2005a] .
Mandibular ex vivo Organ Culture and Treatment with BMP-2
Mandibular condyles were harvested from 3-week-old WT or Bgn -/-Fmod -/-mice (for histology) or 5-week-old mice (for mRNA), dissected in half, and cultured in 24-well plates in DMEM and Pen/Strep antibiotics supplemented with 100 nmol/L ascorbic acid for 24 h. The condyles were then incubated with or without 250 ng/mL human carrier-free recombinant BMP-2 (eBioscience). The left mandibular condyle was treated with BMP-2, and the right was treated with vehicle control. After 2 days, the explant cultures were collected and prepared for histology and quantitative RT-PCR (online suppl. Fig. S1 ; for all online suppl. material, see www.karger.com/doi/10.1159/000464102). For each sample, 5 condyles were combined, and each experiment was repeated at least 3 times.
MicroCT
Treated mandibles were fixed and scanned using a μCT 50 (Scanco Medical AG, Bassersdorf, Switzerland). Scans were performed at 70 kV, 85 μA, 300-ms integration time, and at a resolution of 10 μm. After reconstruction, the images were stored in 3D arrays and used to measure the height of the mandible as shown in Figure 1 a, b.
Quantitative RT-PCR
Expression levels of cartilage-and bone-related genes were analyzed by RT-PCR using RNA obtained from condyles that contained both cartilage and subchondral bone. RNA was isolated using TRIzol (Invitrogen) and purified with RNeasy. cDNA was generated by reverse transcribing total RNA using iScript from BioRad and subjecting it to RT-PCR using SYBER Master Mix (Applied Biosystem) in a BioRad MyiQ quantitative PCR thermocycler. Each cDNA (5-10 ng) was amplified using the primers shown in online supplementary Table S1 . Gene expression was normalized to the housekeeping gene, S29. For each sample, 5 condyles were combined, and each experiment was repeated at least 3 times.
Histology, Staining, and Quantification
Paraffin-embedded sections were dewaxed in xylene washes and rehydrated through graded ethanol series (100, 95, and 75% and water). Tissue sections were stained with hematoxylin and eosin or safranin O. For immunohistochemistry (IHC), rehydrated sections were enzymatically treated with ABCase and incubated with primary antibodies at 4 ° C overnight including polyclonal rabbit antimouse aggrecan (Acan; 1: 100 = 5 mg/mL rabbit IgG catalog No. AB1031; Abcam) and polyclonal rabbit antimouse type I collagen (1: 2,000, rabbit antiserum, LF-68, a gift from Dr. Larry Fisher). The broad-spectrum immunoperoxidase AEC kit (Picture Plus; Zymed) was subsequently used to detect the immunoreactivity according to the manufacturer's instructions. The sections were counterstained with hematoxylin. Images of the stained sections were captured, and the area of positive staining accessed using software from Image-Pro. Nonimmune immunoglobulins of the same isotype as the primary antibody served as negative controls, and showed no positive staining (not shown). Safranin O-positive staining in the treated TMJs was also accessed using Image-Pro software (online suppl. Fig. S2 ). Osteoclast formation was estimated by counting the number of tartrate-resistant acid phosphatase (TRAP; 387A Sigma)-positive multinucleated cells in 5-7 sections/ sample.
Statistical Analysis
Values are presented as means ± SD. Statistical significance of differences among means was determined by two-way analysis of variance with post hoc analysis by the Bonferroni method using SPSS. Statistical significance was defined as p < 0.05.
Results
The experimental strategy for examining BMP-2 function in ex vivo explants is outlined in online supplementary Figure S1 . Briefly, hemi-mandibles were dissected from the heads of WT and Bgn -/-Fmod -/-mice and included the entire condyle with its subchondral bone.
Samples from 3-week-old mice were used for histology while 5-week-old mice were used for mRNA extraction. The hemi-mandibles were then cultured in the presence or absence of BMP-2 for 48 h and processed for microCT, histology, and mRNA isolation for RT-PCR.
Hemi-mandibles from WT and Bgn -/-Fmod -/-mice incubated with or without BMP-2 were first analyzed by microCT to determine the relative height of the condyle after treatment ( Fig. 1 a) . This analysis showed that WT condyles responded with a slight but significant increase in length ( Fig. 1 b) , but the Bgn -/-Fmod -/-condyles did not. This finding prompted us to further examine the underlying cell and molecular foundation by histology, IHC, and quantitative RT-PCR.
At 3 weeks of age, the TMJ is composed of a thick fibrocartilage surface that covers a layer of cartilage that can be clearly visualized by staining with safranin O (online suppl. Fig. S2 ). The cartilage layer lies on top of the subchondral bone that composes the majority of the condyle structure. The area of safranin O-positive staining in WT mandibles treated with BMP-2 was unchanged after the 48-h BMP treatment. However, the area of safranin O in condyles from Bgn -/-Fmod -/-mice was significantly increased ( Fig. 2 a, b) . To confirm these observations, we next stained the sections for the expression of Acan, a known marker of differentiated cartilage tissue. This showed that BMP-2 slightly increased the extent of Acan staining in WT tissue and more so in the Bgn -/-
Fmod
-/-condyles ( Fig. 2 c, d ). When the relative expression of mRNA for Acan was examined with BMP-2 treatment, we found that both WT and Bgn the BMP-2 response was much more robust that in the WT ( Fig. 2 e) . To deepen our understanding of the molecular basis for the observed changes that we saw in cartilage tissue morphology, the mRNA expression levels for additional key cartilage genes were determined. This analysis showed that BMP-2 increased the levels of type II collagen ( Col2 ; Fig. 3 a) and type X collagen ( Col10 ; Fig. 3 b) , Sox9 , the master gene known to regulate cartilage formation ( Fig. 3 c) , and the chondrocyte controlling gene Ihh ( Fig. 3 d) gether, these data showed that the Bgn -/-Fmod -/-condyles are more sensitive to the effects of BMP-2 causing expansion of the cartilage zone resulting in increased levels of safranin O, Acan-positive tissue, as well in the expression of the cartilage-related genes Col2 , Col10 , Sox9 , and Ihh . We next examined the effects of BMP-2 on the proteins and mRNAs that are made by the surrounding fibrocartilage and bone. This analysis showed that the extent of type I collagen (Col1) in the fibrocartilage was slightly increased (but not significantly) in WT condyles treated with BMP-2, and that the Bgn -/-
-/-condyles were much more responsive ( Fig. 4 a) . RT-PCR of mRNA encoding Col1 mRNA showed a parallel significant increase in type I collagen in the Bgn -/-
-/-condyles treated with BMP-2 compared with similarly treated WT explants ( Fig. 4 b) . The master gene, Runx2 , known to regulate many bone-enriched genes, including type I collagen, was found to be regulated in the same manner as type I collagen ( Fig. 4 c) . Osterix ( Osx ), the master regulatory factor operating downstream of Runx2 , showed a different pattern compared to Runx2 whereby induction by BMP-2 in WT condyles was almost (but not completely) at the same level as the Bgn -/-
-/-condyles ( Fig. 4 d) . A downstream target of Wnt called Wisp1/ Ccn4 , which is known to control bone turnover, was also examined and showed constitutive elevation in WT versus Bgn
, and that this increased expression was further enhanced by treatment with BMP-2 ( Fig. 4 e) .
The enhancement of genes known to regulate bone and cartilage formation led us to question whether skeletal turnover in the Bgn 
-/-condyles were treated with BMP-2 and stained for TRAP to identify osteoclasts. This analysis showed that the number of multinucleated TRAP-positive cells was not significantly changed in BMP-2-treated WT condyles; in contrast, Bgn -/-
-/-condyles showed a higher number of TRAP-positive cells that was increased with BMP-2 ( Fig. 5 a) . Analysis of mRNA for TRAP ( Acp5 ) showed a similar outcome where BMP-2-treated Bgn
-/-condyles had much greater expression than BMP-2-treated WT samples ( Fig. 5 b) . Interestingly, untreated Bgn
-/-condyles also had elevated TRAP mRNA expression compared to untreated WT condyles. Analysis of additional catabolic mRNAs, Rankl ( Fig. 5 c) and Adamts4 ( Fig. 5 d) , showed a similar pattern to TRAP mRNA where the Bgn
-/-condyles had constitutively higher levels than WT condyles.
BMP-2 treatment of Bgn -/-
Fmod
-/-condyles further increased Rankl and Adamts mRNA compared to WT controls. 
Discussion
For patients who experience TMJ-OA, irreversible degeneration of the joint often occurs prior to detection or diagnosis. Thus, early detection and diagnosis with biomarkers could lead to early intervention and reduce the incidence of irreversible damage to the TMJ. The goal of this study was to determine whether excessive BMP-2 signaling results in overactivation of chondrogenesis in a Bgn
Fmod
-/ -model of TMJ-OA. Results from this study illustrate that BMP-2 treatment potentiated the induction of Acan , Col2 , Col 10 , and Ihh in Bgn -/-Fmod -/-mice. Excess BMP-2 signaling has also been implicated in the pathogenesis of accelerated TMJ-OA in Pgr4-knockout (KO) mice [Bechtold et al., 2016] . In contrast, absence of BMP signaling in transgenic mice with Bmp1Ra conditionally deleted in neural crest cells led to failure of articular disk separation from the hypoplastic condyle and underdevelopment of the mandibular condylar cartilage [Gu et al., 2014] . Taken together, the results suggest that a threshold of BMP-2 is needed for normal TMJ development.
The mandibular condylar cartilage is unique in that it is derived from the periosteum and undergoes endochondral ossification. In other growth plates, it is believed that there are a finite number of progenitor cells, and once these cells are depleted, growth stops [Hinton et al., 2015] . A similar mechanism may occur in the TMJ. In mice, for example, the mandibular condylar cartilage rapidly undergoes endochondral ossification until 2 months of age [Ghassemi et al., 2017] . Afterwards, the mandibular condylar cartilage becomes senescent and phenotypically resembles other articular cartilages [Livne et al., 1985] . Therefore, in the absence of Bgn and Fmod, excessive BMP-2 signaling may cause accelerated progenitor cell depletion resulting in accelerated age-related TMJ degeneration. Future studies will focus on delivering BMP-2 inhibitors to young (growing) and adult (nongrowing) mice to examine if they can inhibit age-related TMJ-OA in the Bgn -/-Fmod -/-mice in order to further test this hypothesis.
It is well known that Acan is a major proteoglycan in cartilage and that it has important roles in regulating cartilage integrity. In the present study, we focused on Bgn and Fmod because we found they are both abundantly expressed and localized in the articular cartilage of the mandibular condyle [Wadhwa et al., 2005a] . Interestingly, in the Bgn -/-
-/-condyles, the expression of Acan is first increased at 3 and 5 weeks of age, and it decreased with further reduction at 24 weeks of age compared to WT condyles. We believe this is due, in part, to overactive TGF-β production leading to an up-regulation of proteolytic enzymes that degrade Acan including Adamts4 and Adamts5 [Embree et al., 2010] . In this context, we cannot exclude the possibility that some of the effects we see in the BMP-2 responsiveness in the Bgn -/-
-/-mice could, in fact, be from alterations in Acan levels and function.
In our previous study, we found that TGF-β signaling was elevated in Bgn 
